For PCOS patients, an endometrial preparation using GnRH agonist pretreatment prior to artificial cycle could improve implantation rates and clinical pregnancy rates compared with the conventional artificial cycle protocol without GnRH-a pretreatment. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.